Compounds, curing agents, curable resin compositions, cured products, and methods for producing compounds
A pyrazole or 1,2,3-triazole-based curing agent addresses the storage stability and latency issues of nitrogen-containing aromatic compounds, ensuring stable compositions and controlled curing in curable resin systems.
Patent Information
- Application Number
- JP2025078312
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2025-05-08
- Publication Date
- 2026-11-19
AI Technical Summary
Nitrogen-containing aromatic compounds used in curable resin compositions suffer from poor storage stability and the risk of premature curing at room temperature, necessitating a curing agent with latency and improved storage stability.
A compound represented by formula (1) with a pyrazole or 1,2,3-triazole skeleton is used as a curing agent, which exhibits good storage stability and latent curing properties, preventing curing during long-term storage at room temperature.
The compound provides a curing agent with excellent storage stability and controlled curing initiation, allowing for safe long-term storage and effective curing at elevated temperatures, suitable for one- or two-component curable resin compositions.
Smart Images

Figure 2026182244000001 
Figure 2026182244000002 
Figure 2026182244000003
Abstract
Description
[Technical Field]
[0001] The present invention relates to compounds, curing agents, curable resin compositions, cured products, and methods for producing compounds. [Background technology]
[0002] Thermosetting resins such as epoxy resins have excellent mechanical and thermal properties and are widely used in various fields. Furthermore, their cured products have excellent mechanical, thermal, and chemical resistance properties, making them suitable for a wide range of applications including paints, electrical and electronic insulating materials, and adhesives. In the use of such thermosetting resins, nitrogen-containing aromatic compounds have been combined with them for various purposes.
[0003] For example, Patent Document 1 discloses a curable composition comprising a polysiloxane having epoxy groups and a specific nitrogen-containing aromatic compound. This technology aims to provide a polysiloxane with low dielectric properties by using a specific nitrogen-containing aromatic compound in the curing reaction of a curable resin composition.
[0004] Furthermore, Patent Document 2 discloses a curable resin composition comprising at least one resin selected from polyimide precursors, polyamideimide precursors, and polybenzoxazole precursors, and a specific nitrogen-containing aromatic compound. This technology aims to provide a curable resin composition that exhibits excellent storage stability of the composition and film strength of the resulting cured film by incorporating a specific nitrogen-containing aromatic compound.
[0005] Nitrogen-containing aromatic compounds have a wide range of applications and are known to be used as reaction substrates in polymerization reactions. For example, Patent Document 3 proposes specific 1,2,4-triazole derivatives as compounds that have reactivity comparable to acid chlorides with amine compounds and alcohol compounds. [Prior art documents] [Patent Documents]
[0006] Patent Document 1 Japanese Unexamined Patent Application Publication No. 2024-161834 Patent Document 2 International Publication No. 2020 / 262228 Patent Document 3 Japanese Unexamined Patent Application Publication No. 2013-231027 Summary of the Invention Problems to be Solved by the Invention
[0007] It has been found that the nitrogen-containing aromatic compounds described in Patent Documents 1 to 3 have a drawback of poor storage stability of the compounds themselves, making them unsuitable for long-term storage.
[0008] Furthermore, when the curing agent in the curable resin composition has curability near room temperature, there is a risk that curing will start during storage of the curable composition. Therefore, the curing agent is required to have no curability at room temperature, and to be capable of controlling the curing start timing, for example, by temperature (to have latency).
[0009] An object of the present invention is to provide a compound that combines latency as a curing agent and good storage stability of the compound itself, and a method for producing the same. Another object of the present invention is to provide a curing agent composed of the above compound, a curable composition containing the curing agent, and a cured product thereof. Means for Solving the Problems
[0010] [1] A compound represented by the following formula (1).
Chemical Formula
Chemical Formula
[0011] According to the present invention, it is possible to obtain a compound that combines potential as a curing agent with good storage stability of the compound itself, and a method for producing the same. Furthermore, the present invention makes it possible to obtain a curing agent comprising the above-mentioned compound, a curable composition containing the curing agent, and a cured product thereof. [Modes for carrying out the invention]
[0012] <Explanation of Terms> In this specification, "divalent aromatic group" refers to a group obtained by removing two hydrogen atoms from an aromatic compound. Here, "aromatic compound" refers to a compound containing an aromatic ring, and the "aromatic ring" may be an aromatic hydrocarbon ring composed only of carbon and hydrogen atoms, or an aromatic heterocycle containing heteroatoms in addition to carbon and hydrogen atoms. The "aromatic ring" may be a monocyclic ring or a polycyclic ring. In the case of a polycyclic ring, it may be a fused polycyclic ring, and multiple aromatic rings may be linked via linking groups (single bonds, aliphatic groups, or heteroatom-containing groups, etc.). Examples of "aromatic rings" include those with 4 to 20 ring constituent atoms, and preferably those with 6 to 14 ring constituent atoms. The aromatic ring may be substituted, and examples of "substituents" include alkyl groups, alkoxy groups, aryloxy groups, dialkylamino groups, diarylamino groups, alkylarylamino groups, alkylcarbonyl groups, arylcarbonyl groups, alkyloxycarbonyl groups, aryloxycarbonyl groups, alkylcarbonyloxy groups, arylcarbonyloxy groups, alkylthio groups, and arylthio groups. These groups may also be substituted with halogen atoms, for example, alkyl halides. The "substituent" may be a halogen atom, a cyano group (-CN), a nitro group, a hydroxyl group (-OH), a thiol group (-SH), etc.
[0013] In this specification, "divalent aliphatic group" means a group obtained by removing two hydrogen atoms from an aliphatic compound. Here, an aliphatic compound refers to a compound that does not contain an aromatic ring but contains an aliphatic hydrocarbon moiety. This compound may consist only of carbon atoms and hydrogen atoms, or it may contain heteroatoms in addition to carbon atoms and hydrogen atoms. The aliphatic hydrocarbon moiety may be in the form of a chain or a ring. The aliphatic hydrocarbon portion may be substituted, and examples of substituents include halogen atoms, cyano groups (-CN), nitro groups, hydroxyl groups (-OH), and thiol groups (-SH).
[0014] In this specification, "heteroatom" refers to an atom other than carbon and hydrogen atoms, such as oxygen, nitrogen, sulfur, silicon, and halogen atoms. Examples of "halogen atoms" include fluorine, chlorine, bromine, and iodine atoms.
[0015] In this specification, the "alkyl group" may be linear or branched, and preferably has 1 to 6 carbon atoms. Examples include methyl, ethyl, propyl, and isopropyl groups. In this specification, the "aryl group" preferably has 6 to 12 carbon atoms, and examples include a phenyl group, a naphthyl group, and the like.
[0016] In this specification, "alkoxy group" means a monovalent group in which an alkyl group is bonded to an oxygen atom, R a1 -O-(R a1 This refers to a group represented by an alkyl group. In this specification, "aryloxy group" means a monovalent group formed by bonding an aryl group to an oxygen atom, R a2 -O-(R a2 This refers to a group represented by an aryl group.
[0017] In the present specification, the "dialkylamino group" means a monovalent group formed by bonding two alkyl groups to a nitrogen atom, and R a1 -(R a1 -)N-(R a1 is an alkyl group). In the present specification, the "diarylamino group" means a monovalent group formed by bonding two aryl groups to a nitrogen atom, and R a2 -(R a2 -)N-(R a2 is an aryl group). In the present specification, the "alkylarylamino group" means a monovalent group formed by bonding one alkyl group and one aryl group to a nitrogen atom, and R a1 -(R a2 -)N-(R a1 is an alkyl group, R a2 is an aryl group).
[0018] In the present specification, the "alkylcarbonyl group" means a monovalent group formed by bonding an alkyl group to one side of a carbonyl group, and R a1 -C(=O)-(R a1 is an alkyl group). In the present specification, the "arylcarbonyl group" means a monovalent group formed by bonding an aryl group to one side of a carbonyl group, and R a2 -C(=O)-(R a2 is an aryl group).
[0019] In the present specification, the "alkyloxycarbonyl group" means a monovalent group formed by bonding an alkoxy group to one side of a carbonyl group, and R a1 -O-C(=O)-(R a1 is an alkyl group). In the present specification, the "aryloxycarbonyl group" means a monovalent group formed by bonding an aryloxy group to one side of a carbonyl group, and R a2 -O-C(=O)-(R a2This refers to a group represented by an aryl group.
[0020] In this specification, "alkylcarbonyloxy group" means a monovalent group formed by bonding an alkylcarbonyl group to an oxygen atom, R a1 -C(=O)-O-(R a1 This refers to a group represented by an alkyl group. In this specification, "arylcarbonyloxy group" means a monovalent group formed by the bonding of an arylcarbonyl group to an oxygen atom, R a2 -C(=O)-O-(R a2 This refers to a group represented by an aryl group.
[0021] In this specification, "alkylthio group" means a monovalent group in which an alkyl group is bonded to a sulfur atom, R a1 -S-(R a1 This refers to a group represented by an alkyl group. In this specification, "arylthio group" means a monovalent group formed by bonding an aryl group to a sulfur atom, R a2 -S-(R a2 This refers to a group represented by an aryl group.
[0022] <Compound> The compound of the present invention is a compound represented by the following formula (1) (hereinafter also referred to as the compound of formula (1)). [ka] (In the formula, R is a divalent aromatic group or a divalent aliphatic group. E and E' are each independently represented by the following equations (1-c) or (1-d). [ka] (In formula (1-c), R1, R2, and R3 are each independently a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or a halogen atom. Of R1, R2, and R3, two adjacent elements may form a ring together. * indicates a bonding operation. [ka] (In formula (1-d), R4 and R5 are, independently, a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or a halogen atom. R4 and R5 may together form a ring. * indicates a coupling.
[0023] The compounds of the present invention have a pyrazole skeleton or a 1,2,3-triazole skeleton, and are therefore thought to exhibit good storage stability (for example, storage stability at room temperature and under high humidity conditions). Although the mechanism is not clear, compared to bases such as imidazole and 1,2,4-triazole, pyrazole and 1,2,3-triazole are presumed to be unstable after degradation, judging from their structures after degradation. Therefore, the compounds of the present invention are less likely to degrade, and are thought to have excellent storage stability.
[0024] In formula (1), R is a divalent aromatic group or a divalent aliphatic group.
[0025] Examples of divalent aromatic groups include structures represented by the following formula. [ka] (In the formula, L is a single bond, -CH2-, -C(CH3)2-, -S(=O)2-, -C(=O)-, -S-, or -O-. Ra' is independently a hydrogen atom, an alkyl group, an alkoxy group, an aryloxy group, a dialkylamino group, a diarylamino group, an alkylarylamino group, an alkylcarbonyl group, an arylcarbonyl group, an alkyloxycarbonyl group, an aryloxycarbonyl group, an alkylcarbonyloxy group, an arylcarbonyloxy group, an alkylthio group, or an arylthio group, and these groups may be substituted with halogen atoms, or Ra' is a halogen atom, a cyano group (-CN), a nitro group, a hydroxyl group (-OH), or a thiol group (-SH). * indicates a bonding operation.
[0026] Ra' is preferably a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or a halogen atom.
[0027] When Ra' is a hydrogen atom, examples of the above groups include phenylene group, naphthylene group, biphenylene group, anthracene group, phenanthrene group, phenylenemethylenephenylene group, sulfonyldiphenylene group, etc., with the phenylene group being preferred.
[0028] When R is represented by the above formula (α-1), the compounds of the present invention include the compounds represented by the following formula (1-a). [ka] (In the formula, Ra is independently a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or a halogen atom. E and E' are equivalent to equation (1).
[0029] Formula (1-a) encompasses compounds represented by the following formulas (1-a-1), (1-a-2), and (1-a-3), depending on the bond positions of the EC(=O)- and E'-C(=O)- attached to the phenylene group. [ka] (In the formula, Ra is independently a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or a halogen atom. E and E' are equivalent to equation (1). Here, Ra is preferably a hydrogen atom.
[0030] In R, the EC(=O)- and E'-C(=O)- bonds attached to the phenylene group are preferably 1,4-bonds. R is more preferably a 1,4-phenylene group.
[0031] In R, the aliphatic hydrocarbon portion of the divalent aliphatic group may be a saturated aliphatic hydrocarbon residue or an unsaturated aliphatic hydrocarbon residue, but it is preferable that it be a saturated aliphatic hydrocarbon residue.
[0032] Examples of saturated aliphatic hydrocarbon residues include alkylene groups or cycloalkylene groups, or combinations thereof. The alkylene groups can be linear or branched. They may be unsubstituted or substituted, and the substituents may be halogen atoms, cyano groups (-CN), nitro groups, hydroxyl groups (-OH), or thiol groups (-SH).
[0033] The alkylene group can be an alkylene group having 1 to 20 carbon atoms, with an alkylene group having 1 to 10 carbon atoms being preferred. Examples of alkylene groups include methylene, ethylene, propylene, isopropylene, tetramethylene, isobutylene, sec-butylene, tert-butylene, n-pentylene, isopentylene, tert-pentylene, neopentylene, 1,2-dimethylpropylene, and n-decene.
[0034] The cycloalkylene group can be a cycloalkylene group having 3 to 20 carbon atoms, and is preferably a cycloalkylene group having 3 to 10 carbon atoms. Examples of cycloalkylene groups include cyclopropylene, cyclobutylene, cyclopentylene, and cyclohexylene.
[0035] R is preferably a substituted or unsubstituted alkylene group, and more preferably a substituted or unsubstituted linear alkylene group.
[0036] R is more preferably a tetramethylene group.
[0037] When R is a substituted or unsubstituted linear alkylene group, the compounds of the present invention include the following formula (1-b). [ka] (In the formula, R b Each of these is independently either a hydrogen atom or a halogen atom. E and E' are equivalent to equation (1), m b (This is an integer between 1 and 20.) Here, R b It is even more preferable that all of them are hydrogen atoms. b Preferably, it is an integer between 1 and 10.
[0038] In equation (1), E and E' are structures that can be independently represented by equation (1-c) or (1-d). [ka] (In formula (1-c), R1, R2, and R3 are each independently a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or a halogen atom. Of R1, R2, and R3, two adjacent elements may form a ring together. * indicates a bonding operation. [ka] (In formula (1-d), R4 and R5 are, independently, a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or a halogen atom. R4 and R5 may together form a ring. * indicates a bonding operation.
[0039] Formula (1-c) represents a pyrazole ring structure. [ka] (In the formula, R1, R2, and R3 are each independently a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or a halogen atom.) Of R1, R2, and R3, two adjacent elements may form a ring together. * indicates a bonding operation. Among R1, R2, and R3, the cyclic structure formed by the combination of two adjacent rings can be a ring with 3 to 15 constituent atoms, and may be a carbon ring or a heteroatom-containing ring, and may be an aromatic ring or a non-aromatic ring. The aromatic ring may be an aromatic hydrocarbon ring or an aromatic heterocycle. Furthermore, the ring may be a monoring or a fused ring. Examples include cyclohexane rings, benzene rings, naphthalene rings, pyridine rings, pyrimidine rings, etc. Examples of the above-mentioned annular structures include the annular structure formed by R1 and R2, and the annular structure formed by R2 and R3.
[0040] In formula (1-c), R1, R2, and R3 are preferably hydrogen atoms or methyl groups. Furthermore, it is preferable that R1, R2, and R3 are all hydrogen atoms, or more preferably that R1 and R3 are methyl groups and R2 is a hydrogen atom. In other words, it is preferable that the structure of E or E' is pyrazole or 3,5-dimethylpyrazole.
[0041] In the structure of formula (1-c), if R1 and R3 are methyl groups and R2 is a hydrogen atom, then E or E' can be represented by the structure shown in the following formula. [ka] (In the formula, * represents a coupling.) In the structure of formula (1-c), if R1, R2, and R3 are all hydrogen atoms, then E or E' can be represented by the structure shown in the following formula. [ka] (In the formula, * represents a coupling.)
[0042] Formula (1-d) represents a 1,2,3-triazole ring structure. [ka] (In the formula, R4 and R5 are each independently a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or a halogen atom.) R4 and R5 may form a ring together. * indicates a bonding operation. Here, the cyclic structure formed by R4 and R5 can be a ring with 3 to 15 constituent atoms, and may be a carbon ring or a heteroatom-containing ring, and may be an aromatic ring or a non-aromatic ring. The aromatic ring may be an aromatic hydrocarbon ring or an aromatic heterocycle. Furthermore, the ring may be a monoring or a fused ring. Examples of ring structures include a cyclohexane ring, a benzene ring, a naphthalene ring, a pyridine ring, a pyrimidine ring, etc. It is preferable that R4 and R5 form a benzene ring. In other words, it is preferable that the structure of E or E' is a 1,2,3-benzotriazole structure.
[0043] In the structure of formula (1-d), if R4 and R5 form a benzene ring, it can be represented by the structure of formula (1-d-1) below. [ka] (In the formula, R6, R7, R8, and R9 are each independently a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or a halogen atom.) * indicates a bonding operation.
[0044] In the structure of formula (1-d-1), R6, R7, R8, and R9 are preferably hydrogen atoms, and more preferably all of R6, R7, R8, and R9 are hydrogen atoms. When all of R6, R7, R8, and R9 are hydrogen atoms, E and E' can be represented by the following structures. [ka]
[0045] The compounds of the present invention exhibit superior storage stability compared to compounds in which the structures corresponding to E and E' are 1,2,4-triazole ring structures or imidazole ring structures.
[0046] E and E' may be the same or different, but it is preferable that they be the same.
[0047] In formula (1), when R is a phenylene group, E and E' are either a pyrazole ring structure or a 1,2,3-triazole ring structure, and Ra is all hydrogen atoms, they can be represented by the following formulas. [ka] (In the formula, R1, R2, and R3 are equivalent to those in formula (1-c), and the same applies to the preferred examples. R4 and R5 are equivalent to those in formula (1-d), and the same applies to the preferred examples.
[0048] In the compounds of formulas (1-1-1), (1-2-1), and (1-3-1), when the phenylene group is a 1,4-phenylene group, they can be represented by the following formulas, respectively. [ka] (In the formula, R1, R2, and R3 are equivalent to those in formula (1-c), and the same applies to the preferred examples. R4 and R5 are equivalent to those in formula (1-d), and the same applies to the preferred examples.
[0049] In formulas (1-1-2), (1-2-2), and (1-3-2), if the pyrazole ring structure is pyrazole or 3,5-dimethylpyrazole and the 1,2,3-triazole ring structure is 1,2,3-benzotriazole, it can be represented by the following formula. [ka]
[0050] Furthermore, in the compound of formula (1), when R is an unsubstituted linear alkylene group, the respective formulas can be expressed as follows. [ka] (In the formula, mb is synonymous with formula (1-b), and the preferred example is similar. R1, R2, and R3 are equivalent to those in formula (1-c), and the same applies to the preferred examples. R4 and R5 are equivalent to those in formula (1-d), and the same applies to the preferred examples.
[0051] In the compounds of formulas (1-4-1), (1-5-1), and (1-6-1), when mb is 4, they can be represented by the following formulas, respectively. [ka] (In the formula, R1, R2, and R3 are equivalent to those in formula (1-c), and the same applies to the preferred examples. R4 and R5 are equivalent to those in formula (1-d), and the same applies to the preferred examples. In formulas (1-4-2), (1-5-2), and (1-6-2), if the pyrazole ring structure is pyrazole or 3,5-dimethylpyrazole and the 1,2,3-triazole ring structure is 1,2,3-benzotriazole, it can be represented by the following formula. [ka]
[0052] <Hardening agent> The compound of the present invention can be used as a curing agent for curable resins. Because this curing agent has latent properties, when it is used in a composition with a curable resin, the curing start temperature of the curable resin composition is sufficiently higher than room temperature, preventing thickening and gelation during long-term storage of the curable resin composition. As a result, the compound of the present invention can be used as a one-component curing agent. Furthermore, because this curing agent has excellent storage stability, it can also be preferably used as a two-component curing agent.
[0053] The curing agent of the present invention comprises a compound represented by formula (1).
[0054] <Curable resin composition> The curable resin composition of the present invention comprises the curing agent of the present invention and a curable resin.
[0055] (Hardening agent) The curable resin composition of the present invention contains the curing agent of the present invention. The amount of curing agent in the curable resin composition can be 0.1 to 200 parts by mass per 100 parts by mass of the curable resin.
[0056] Nitrogen-containing compounds, such as the compound of the present invention, can impart flame retardancy to compositions through an oxygen dilution effect. The curable resin composition of the present invention, containing the compound of the present invention as a curing agent, can also exhibit excellent flame retardancy. Low molecular weight nitrogen-containing compounds such as imidazoles and pyrazoles volatilize at temperatures lower than the decomposition temperature of the composition due to their sublimation properties and low boiling points, making it impossible to expect effects such as flame retardancy. On the other hand, the compounds of the present invention have low volatility and can remain in the composition even at high temperatures, thus exhibiting good flame retardancy derived from nitrogen-containing compounds.
[0057] (curable resin) The curable resin composition of the present invention comprises a curable resin. Examples of curable resins include epoxy resins, acrylic resins, phenolic resins, cyanate resins, isocyanate resins, maleimide resins, benzooxazine resins, silicone resins, fluororesins, polyamide resins, polyimide resins, polyamideimide resins, and phenoxy resins. Epoxy resins are preferred as the curable resin.
[0058] (optional ingredient) The curable resin composition of the present invention may contain components other than the curing agent and curable resin, as long as they do not impair the effects of the present invention. Specifically, these include curing accelerators, thermoplastic resins, solvents, fillers, mold release agents, antioxidants, flame retardants, thickeners, and the like. The curable resin composition of the present invention is thermosetting, but photocurability may be imparted by the blending of various components (for example, compounds having ethylenically unsaturated groups such as photopolymerizable monomers and photopolymerizable oligomers; photosensitizers such as photopolymerization initiators, photoacid generators, and photobase generators; photoinitiation aids; sensitizers, etc.).
[0059] (Method for producing curable resin compositions) The curable resin composition of the present invention can be manufactured, for example, by mixing the curing agent of the present invention, the curable resin, and any optional components to be added as needed, using a conventionally known method.
[0060] <Cured product> The curable resin composition of the present invention can be cured to produce a cured product. The curing method is not particularly limited and can be carried out by conventionally known methods. For example, a method involving a thermosetting step can be used.
[0061] When curing the curable resin composition of the present invention by thermosetting, a cured product can be obtained by heating at a temperature of 60 to 250°C. The heating time can be set as appropriate, for example, from 1 minute to 2 hours.
[0062] <Method for producing compounds> The compounds of the present invention can be obtained, for example, by the reaction of a dicarboxylic acid compound with pyrazoles and / or 1,2,3-triazoles.
[0063] (Dicarboxylic acid compounds) Dicarboxylic acid compounds are compounds represented by the following formula (1') and their derivatives. [ka] (In the formula, R is equivalent to that in formula (1).)
[0064] In this specification, "dicarboxylic acid compound" includes dicarboxylic acids and derivatives of dicarboxylic acids. Examples of dicarboxylic acid derivatives include dicarboxylic acid acid chlorides and dicarboxylic acid esters. It is preferable to use dicarboxylic acid chloride as the dicarboxylic acid compound. Dicarboxylic acid acid chlorides may be commercially available or can be obtained from the corresponding dicarboxylic acid by known methods.
[0065] When R is a divalent aromatic group, the compound of formula (1') is an aromatic dicarboxylic acid compound, such as terephthalic acid, isophthalic acid, phthalic acid, 2,6-naphthalenedicarboxylic acid, 2,7-naphthalenedicarboxylic acid, 1,4-naphthalenedicarboxylic acid, 2,6-anthracenedicarboxylic acid, 9,10-anthracenedicarboxylic acid, dibenzoic acid, diphenylmethane-4,4'-dicarboxylic acid, diphenylsulfone-4,4'-dicarboxylic acid, 4,4'-biphenyldicarboxylic acid, 3,3'-biphenyldicarboxylic acid, 4,4'-oxybisbenzoic acid, etc. Derivatives of these can also be used. Terephthaloyl chloride is preferred as the aromatic dicarboxylic acid compound.
[0066] When R is a divalent aliphatic group, the compound of formula (1') is an aliphatic dicarboxylic acid compound, such as succinic acid, adipic acid, 1,3-cyclobutanedicarboxylic acid, 1,3-cyclopentanedicarboxylic acid, 1,4-cyclohexanedicarboxylic acid, and 1,10-decanedicarboxylic acid. Derivatives of these can also be used. Adipoyl chloride is preferred as the aliphatic dicarboxylic acid compound.
[0067] (Pyrazoles and / or 1,2,3-triazoles) The pyrazoles used in the production of the compounds of the present invention can be represented by the following formula (1'-c). [ka] (In the formula, R1, R2, and R3 are equivalent to those in formula (1-c).)
[0068] The 1,2,3-triazoles used in the production of the compounds of the present invention can be represented by the following formula (1'-d). [ka] (In the formula, R4 and R5 are equivalent to those in formula (1-d).)
[0069] As for pyrazoles, pyrazole and 3,5-dimethylpyrazole are preferred. As the 1,2,3-triazole, 1,2,3-benzotriazole is preferred.
[0070] The amount of pyrazoles and / or 1,2,3-triazoles used can be such that the total amount of pyrazoles and / or 1,2,3-triazoles is 2 to 10 moles per mole of the dicarboxylic acid compound. Furthermore, when two or more pyrazoles and / or 1,2,3-triazoles are used in combination, it is possible to obtain the compounds of the present invention in which E and E' are different from each other by adjusting the ratio of their use.
[0071] (Neutralizing agent) In the production of the compounds of the present invention, a neutralizing agent can be used. When dicarboxylic acid chloride is used as the dicarboxylic acid compound, hydrogen chloride is produced as a by-product in the reaction with pyrazoles or 1,2,3-triazoles. Therefore, it can be neutralized using a neutralizing agent (base). Examples of neutralizing agents include inorganic neutralizing agents such as calcium hydroxide, calcium carbonate, and lithium carbonate; and organic neutralizing agents such as 1,2-butylene oxide, ethylene oxide, propylene oxide, ethylene carbonate, glycidylphenyl ether, ammonia, triethylamine, and pyridine. Triethylamine or pyridine is preferred as the neutralizing agent.
[0072] The amount of neutralizing agent used can be 2 to 8 moles per mole of dicarboxylic acid compound.
[0073] (Condensing agent) In the production of the compounds of the present invention, a condensing agent can be used. When a dicarboxylic acid is used as the dicarboxylic acid compound, the reaction with pyrazoles or 1,2,3-triazoles can be efficiently carried out by using a condensing agent. Examples of condensing agents include carbodiimide-based condensing agents such as diisopropylcarbodiimide (DIPC), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDAC), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (WSC), and dicyclohexylcarbodiimide (DCC), as well as 4-(4,6-dimethoxy-1,3,5-triazine-2-yl)-4-methylmorpholinium chloride (DMT-MM) and carbonyldiimidazole.
[0074] (solvent) The reaction between pyrazoles or 1,2,3-triazoles and dicarboxylic acid dichlorides can be carried out in an aprotic organic polar solvent. Examples of aprotic organic polar solvents include sulfoxide solvents such as dimethyl sulfoxide and diethyl sulfoxide; formamide solvents such as N,N-dimethylformamide and N,N-diethylformamide; acetamide solvents such as N,N-dimethylacetamide and N,N-diethylacetamide; pyrrolidone solvents such as N-methyl-2-pyrrolidone and N-vinyl-2-pyrrolidone; hexamethylphosphoramide; γ-butyrolactone; and dichloromethane. These aprotic organic polar solvents may be used individually or in combination of two or more. Aromatic hydrocarbons such as xylene and toluene can also be used as solvents.
[0075] The amount of solvent can be 100 to 10,000 parts by mass per 100 parts by mass of the total amount of pyrazoles or 1,2,3-triazoles and dicarboxylic acid compounds used.
[0076] (Synthesis of compounds) The method for synthesizing the compounds of the present invention is not particularly limited. For example, the compounds can be reacted by adding a solution of a dicarboxylic acid compound dissolved in a solvent to a solution of pyrazoles or 1,2,3-triazoles dissolved in a solvent and a neutralizing agent.
[0077] The reaction conditions for producing the compound of the present invention can be a temperature of -30 to 100°C and a time of 1 minute to 27 hours. The reaction may also be carried out under an inert gas atmosphere such as nitrogen gas, argon gas, or helium gas.
[0078] After the reaction is complete, the desired compound can be obtained by purifying the crude product. The purification method is not particularly limited; for example, the solution after the reaction can be added to deionized water, then separated into an aqueous layer and an organic layer, and the organic layer can be concentrated for purification.
[0079] (Properties of the compound) The compound of the present invention is1 H-NMR, 13 Identification can be achieved by measurement using methods such as 1C-NMR and FD-MS. [Examples]
[0080] <Measurement method> Various measurements and evaluations of the compounds in the examples and comparative examples were carried out according to the following procedure. In the following, "%" and "parts" are based on mass unless otherwise specified.
[0081] (1) Storage stability assessment One g of each compound was placed in a sample bottle, and an accelerated test was performed for 14 days at 40°C and 60% RH using a Yamato Scientific IG400 constant temperature and humidity chamber. After the test, the samples were dissolved in a deuterated solvent. 1 1H-NMR was measured. The peak integral values corresponding to each compound and the peak integral values corresponding to the decomposition products were confirmed, and the decomposition rate was determined using the method shown in the formula below. Products with a lower decomposition rate were considered to have better storage stability. The criteria for evaluation were as follows: less than 10% decomposition rate = A, 10% to less than 50% = B, 50% to less than 90% = C, and 90% or more = D. (Decomposition rate %) = [(Integrated value of decomposed products) / {(Integrated value of decomposed products) + (Integrated value of hardener)}] × 100
[0082] (2) Curing temperature evaluation To 100 parts of jER828 (registered trademark) (bisphenol A type epoxy resin, manufactured by Mitsubishi Chemical Corporation), 10 parts of each compound were added as a curing agent and mixed. 4 mg of this mixed sample was measured using a TA Instruments DSC Q100 under a nitrogen atmosphere at a heating rate of 3°C / min from 40°C to 300°C. The curing temperature was defined as the temperature at which the curing peak began. A higher curing temperature of the composition makes it more difficult to initiate curing at room temperature and indicates superior latent curing properties. Each composition was evaluated based on its curing peak initiation temperature, with A assigned to 90°C or higher, B to 80°C or higher and less than 90°C, C to 50°C or higher and less than 80°C, and D to less than 50°C.
[0083] (3) Flame retardancy evaluation 5 mg of each compound was measured using a TGA5500 thermogravimetric analyzer manufactured by T.A. Instrument Japan, under an air atmosphere, from 30°C to 600°C at a heating rate of 10°C / min. From the obtained data, a graph was created with weight loss (%) on the vertical axis and temperature on the horizontal axis. A tangent line was drawn at the temperature range before the weight loss chart changed, and a tangent line was drawn at the temperature where the weight loss began and the slope was maximum. The temperature at which the two tangent lines intersected was defined as the decomposition start temperature. Compounds were evaluated based on their decomposition initiation temperature: A for 250°C or higher, B for 200°C or higher but less than 250°C, and C for less than 200°C.
[0084] <Synthesis of Compounds> (Example 1) In a 300 mL three-necked flask, 12.03 g (0.101 mol) of 1,2,3-benzotriazole, 12.46 g (0.123 mol) of triethylamine, and 50 mL of dichloromethane were charged. Under a nitrogen atmosphere, while stirring with a magnetic stirrer, 10.00 g (0.049 mol) of terephthaloyl chloride suspended in 50 mL of dichloromethane was gradually added, taking care to avoid generating heat. After addition, the mixture was stirred at room temperature for 17 hours. Then, the resulting reaction mixture was added to a beaker containing 200 g of deionized water while stirring. After stirring for a while, the solids were filtered from the resulting suspension and washed with a small amount of water and acetone. The organic layer was extracted from the filtrate using a separatory funnel, and magnesium sulfate (anhydrous) was added to the extracted organic layer and dried. After filtering off the solids (inorganic components) from this organic layer, the solvent was concentrated using an evaporator. By combining these and vacuum drying, 16.56 g of the compound from Example 1 was obtained. The molar yield relative to terephthaloyl chloride was 91.3%. [ka] 1 H-NMR (400MHz, CDCl3): δ=8.45(d, 2H), 8.42(s, 4H), 8.21(d, 2H), 7.77(t, 2H), 7.61(t, 2H)
[0085] (Example 2) Except for using pyrazole instead of 1,2,3-benzotriazole, 10.45 g of the compound of Example 2 was obtained in the same manner as in Example 1. The molar yield relative to terephthaloyl chloride was 79.7%. [ka] 1 H-NMR (400MHz, DMSO-d6): δ=8.64(d, 2H), 8.12(s, 4H), 8.00(d, 2H), 6.76-6.75(m, 2H)
[0086] (Example 3) 8.29 g of the compound of Example 3 was obtained in the same manner as in Example 1, except that 3,5-dimethylpyrazole was used instead of 1,2,3-benzotriazole. The molar yield relative to terephthaloyl chloride was 52.2%. [ka] 1 H-NMR (400MHz, CDCl3): δ=8.03(s, 4H), 6.07(d, 2H), 2.65(s, 6H), 2.24(s, 6H)
[0087] (Example 4) 17.15 g of the compound of Example 4 was obtained in the same manner as in Example 1, except that adipoyl chloride was used instead of terephthaloyl chloride. The molar yield relative to adipoyl chloride was 90.1%. [ka] 1 H-NMR (400MHz, DMSO-d6): δ=8.24(m, 4H), 7.78(t, 2H), 7.61(t, 2H), 3.54(t, 4H), 1.99(quin, 4H)
[0088] (Example 5) Except for using pyrazole instead of 1,2,3-benzotriazole and adipoyl chloride instead of terephthaloyl chloride, 12.39 g of the compound of Example 5 was obtained in the same manner as in Example 1. The molar yield relative to adipoyl chloride was 92.1%. [ka] 1 H-NMR (400MHz, DMSO-d6): δ=8.36(d, 2H), 7.83(d, 2H), 6.57-6.56(m, 2H), 3.12(t, 4H), 1.73(quin, 4H)
[0089] (Comparative Example 1) 11.91 g of the compound for Comparative Example 1 was obtained in the same manner as in Example 1, except that imidazole was used instead of 1,2,3-benzotriazole. The molar yield relative to terephthaloyl chloride was 90.8%. [ka] 1 H-NMR (400MHz, DMSO-d6): δ=8.28(s, 2H), 8.01(s, 4H), 7.76(m, 2H), 7.21-7.20(m, 2H)
[0090] (Comparative Example 2) 8.59 g of the compound for Comparative Example 2 was obtained in the same manner as in Example 1, except that 1,2,3-benzotriazole was used instead of 1,2,4-triazole. The molar yield relative to terephthaloyl chloride was 65.0%. [ka] 1 H-NMR (400MHz, DMSO-d6): δ=8.30-8.24(br, 4H), 8.00(s, 4H)
[0091] The storage stability of the compounds in Examples 1-5 and Comparative Examples 1-2 was evaluated. The results are shown in Table 1. [Table 1]
[0092] Table 1 shows that the compounds in the examples have superior storage stability compared to compounds having an imidazole ring or a 1,2,4-triazole ring.
[0093] The compounds from Examples 1-5, as well as Comparative Examples 3-4, consisting of 2-ethyl-4-methylimidazole (compound of Comparative Example 3, manufactured by Tokyo Chemical Industry Co., Ltd., purity >95%) and pyrazole (compound of Comparative Example 4, manufactured by Tokyo Chemical Industry Co., Ltd., purity >98%), were evaluated for curing initiation temperature and flame retardancy. The results are shown in Table 2. [Table 2]
[0094] Table 2 shows that the compounds in the examples have a higher curing initiation temperature and superior latent properties compared to 2-ethyl-4-methylimidazole and pyrazole. Furthermore, the compounds in the examples also exhibit superior flame retardancy. [Industrial applicability]
[0095] According to the present invention, a compound that combines potential as a curing agent with good storage stability of the compound itself, and a method for producing the same are provided, thus having high industrial utility.
Claims
1. A compound represented by the following formula (1). 【Chemistry 1】 (In the formula, R is a divalent aromatic group or a divalent aliphatic group. E and E' are structures that can be independently represented by the following formulas (1-c) or (1-d). 【Chemistry 2】 (In formula (1-c), R 1 , R 2 and R 3 Each of these is independently a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or a halogen atom. R 1 , R 2 and R 3 Of these, two adjacent ones may come together to form a ring. * indicates a linking hand. 【Transformation 3】 (In formula (1-d), R 4 and R 5 Each of these is independently a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or a halogen atom. R 4 and R 5 may together form a ring, * indicates a linking hand.
2. The compound according to claim 1, wherein R is a 1,4-phenylene group or an alkylene group having 1 to 20 carbon atoms.
3. The compound according to claim 1, wherein E and E' each independently have a structure represented by one of the following formulas. 【Chemistry 4】 (In the formula, * represents a coupling.)
4. A curing agent comprising the compound described in any one of claims 1 to 3.
5. A curable resin composition comprising the curing agent and curable resin described in claim 4.
6. A cured product obtained by curing the curable resin composition described in claim 5.
7. A method for producing a compound according to any one of claims 1 to 3, comprising the step of reacting a compound represented by the following formula (1') or a derivative thereof with a compound represented by the following formula (1'-c) and / or (1'-d). 【Transformation 5】 (In the formula, R is equivalent to that in formula (1).) 【Transformation 6】 (In the formula, R 1 , R 2 , and R 3 This is equivalent to equation (1-c). 【Transformation 7】 (In the formula, R 4 and R 5 This is equivalent to equation (1-d).
Citation Information
Patent Citations
Acyl triazole derivative and method of manufacturing the same
JP2013231027A
Curable composition
JP2024161834A
Curable resin composition, cured film, layered product, method for producing cured film, and semiconductor device
WO2020262228A1
